Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Gross Profit (2021 - 2025)

Lucid Diagnostics' Gross Profit history spans 5 years, with the latest figure at -$360000.0 for Q4 2025.

  • For Q4 2025, Gross Profit rose 87.17% year-over-year to -$360000.0; the TTM value through Dec 2025 reached -$4.5 million, up 53.43%, while the annual FY2025 figure was -$2.0 million, 83.74% up from the prior year.
  • Gross Profit reached -$360000.0 in Q4 2025 per LUCD's latest filing, up from -$497000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $7.1 million in Q4 2023 to a low of -$3.9 million in Q2 2023.
  • Average Gross Profit over 5 years is -$1.0 million, with a median of -$497000.0 recorded in 2025.
  • The largest YoY upside for Gross Profit was 6200.89% in 2023 against a maximum downside of 4118.42% in 2023.
  • A 5-year view of Gross Profit shows it stood at $300000.0 in 2021, then tumbled by 62.67% to $112000.0 in 2022, then surged by 6200.89% to $7.1 million in 2023, then plummeted by 139.78% to -$2.8 million in 2024, then soared by 87.17% to -$360000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Gross Profit are -$360000.0 (Q4 2025), -$497000.0 (Q3 2025), and -$363000.0 (Q2 2025).